<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0255">
 <label>51</label>
 <element-citation publication-type="journal" id="h0255">
  <person-group person-group-type="author">
   <name>
    <surname>Novi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mikulska</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Briano</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Toscanini</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Tazza</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Uccelli</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?</article-title>
  <source>Multiple Sclerosis Related Disorders</source>
  <volume>42</volume>
  <year>2020</year>
 </element-citation>
</ref>
